Stem Cell Therapy deal

SCII acquired exclusive worldwide rights to anti-rejection umbilical cord blood stem cell technology from inventors Calvin Cao and Lixian Jiang. Cao is SCII's CEO and Jiang is COO and Patent Trademark...